US Stock MarketDetailed Quotes
PALI Palisade Bio
- 4.3300
- -0.0200-0.46%
Close Jul 19 16:00 ET
4.05MMarket Cap-184P/E (TTM)
4.8900High3.8746Low392.56KVolume4.8770Open4.3500Pre Close1.78MTurnover47.31%Turnover RatioLossP/E (Static)936.40KShares34.275052wk High0.40P/B3.59MFloat Cap3.820052wk Low--Dividend TTM829.81KShs Float594000.0000Historical High--Div YieldTTM23.34%Amplitude3.8200Historical Low4.5290Avg Price1Lot Size
Palisade Bio Stock Forum
Sign in to post a comment
$Palisade Bio(PALI.US$ Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, Pali-2108
1
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product.
Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade" or the "Company"), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, has recently made a advancement in its drug development progr...
Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade" or the "Company"), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, has recently made a advancement in its drug development progr...
$Palisade Bio(PALI.US$ here boy, get yourself up to 10 dollar
$Palisade Bio(PALI.US$ wait open market to see the volume
$Palisade Bio(PALI.US$ Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
Palisade Bio, Inc.Thu, 11 July 2024 at 8:00 am GMT-4
Palisade Bio, Inc.Thu, 11 July 2024 at 8:00 am GMT-4
1
$Palisade Bio(PALI.US$
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
Palisade Bio announced the successful completion of the first GMP manufacturing batch of its drug substance PALI-2108, targeted for treating moderate-to-severe ulcerative colitis (UC).
The company partnered with Eurofins for process development and scale-up. The drug substance has been utilized in completed murine and non-murine G...
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
Palisade Bio announced the successful completion of the first GMP manufacturing batch of its drug substance PALI-2108, targeted for treating moderate-to-severe ulcerative colitis (UC).
The company partnered with Eurofins for process development and scale-up. The drug substance has been utilized in completed murine and non-murine G...
$Palisade Bio(PALI.US$
now does that look nootropic AF or what?....
lol, I'm always noticing the Benzylpiperazine (BZP) structure within the skeleton. now that would be fun 😊
now does that look nootropic AF or what?....
lol, I'm always noticing the Benzylpiperazine (BZP) structure within the skeleton. now that would be fun 😊
1
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108.
Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company dedicated to developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, has recently announced a milestone in its intellectual property portfolio. The Canadian Intellectual Property Office (CIPO) has issued a Notice of All...
Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company dedicated to developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, has recently announced a milestone in its intellectual property portfolio. The Canadian Intellectual Property Office (CIPO) has issued a Notice of All...
$Palisade Bio(PALI.US$
NEWS
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
NEWS
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
$Palisade Bio(PALI.US$ NICE. PRIVATE PLACEMENT AT 6.50. Bullish. Big news coming!!
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Benjamin’s : For whatever reason this stock can’t hold gains. Eventually someday it will surprise everyone.